PariS -TBI Study: Paris Severe Traumatic Brain Injury Study - 8 Years (TCS8)

November 17, 2017 updated by: Assistance Publique - Hôpitaux de Paris

Eight-year Outcome and Health Care After Severe Traumatic Brain Injury in the Parisian Area

The objective of the protocol is to pursue the long-term follow-up of a large cohort of severe traumatic brain injury patients. This outcome is to be described in terms of activity, participation, quality of life, socio-professional outcome, economical consequences and impact on caregivers, and in relation to health care provision.

Secondary objectives are to measure the impact on outcome of several predictive factors; to evaluate evolution of patients since the last (four-year) evaluation.

Study Overview

Detailed Description

This work represents a part of a larger collaborative prospective study called PariS-TBI (Severe Traumatic Brain Injury in the Parisian area) financed by the French National Authority for Health. The Paris-TBI study was undertaken in 2004, to provide epidemiological data. Patients aged 15 or more were included if they had sustained a severe TBI in the Parisian area during a 20-months period (2005-2007), defined by an initial Coma Glasgow Score (GCS) of 8 or less. Data from patients' demographics, injury characteristics, acute and post acute phase were collected prospectively. A total of 504 patients were included, of which 257 were alive at the time of this study. Patients (n = 134) were evaluated through a phone interview at one year post traumatism, and had a face-to-face evaluation at four years post-injury (n = 147).

Investigations of the present work will be undertaken at eight years after the injury. Patients of the initial cohort will be contacted through post and phone call. Information about this follow up study will be given orally and through written form. Informed consent of patient or legal advisor will be obtained before setting an appointment for the evaluation.

Evaluation will take place either in the patient's place of living, or in a clinical setting in the hospitals Broussais, Paris, France or Raymond Poincaré, Garches, France, according to the patient's choice.

A trained neuropsychologist will lead the evaluations, during an interview with the patient and the informal caregiver, defined as the person (family member or friend), most responsible for day-to-day decision making and care for the patient. If a patient cannot attend the interview, a short questionnaire will be proposed to him by the neuropsychologist by phone.

Demographic and pre-traumatism clinical data will be available from the initial study, as well as data on type and severity of traumatism, and on evolution during acute care. Data from the one-year and the four-year assessments will be available.

Data assessed through the present study will include an evaluation of deficiencies: presence of somatic deficiencies, mood difficulties (Hospital Anxiety and Depression Score), cognitive deficiencies (Dysexecutive Questionnaire, questionnaire of complaints, filled in both by the patient himself and by his proxy). Neuropsychological testing will include the California Verbal Learning Test, Trail Making Test, the WAIS-IV Processing Speed Index, and the 6-Elements Test.

Activities will be evaluated by the Glasgow Outcome Scale-Extended, and specifically through questions addressing driving ability, and ability to perform instrumental activities.

Professional activity and change, and quality of life at work will be assessed through a standardized questionnaire.

Data on patients' clinical care and services will be collected, including medical care, therapies, home assistance, socio-vocational assistance. Unmet need of services and barriers to care access will be assessed through a standardized questionnaire.

Data on the quality of life of the informal caregiver and an evaluation of the burden of care will be collected, using the ZARIT questionnaire. Data on economical consequences of the injury on the patient, and on his care provider will be collected.

The exploitation of this large database will enable an up-to-date description of the long term outcomes of severe TBI patients in the Parisian area. It will be used to clarify the role of several factors on long term activities and participations and on informal care burden.

The comparison with the previous evaluations will allow evaluation of late evolution and of its determinants.

Study Type

Observational

Enrollment (Anticipated)

130

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75014
        • CRFTC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients had severe TC in the Parisian area between 2005 and 2008 and were evaluated 4 years.

Description

Inclusion Criteria: all patients initially included in the Paris-TBI cohort, alive at time of evaluation. i.e.

  • Adults
  • Severe TBI with a Glasgow Coma Scale (GCS) score of 8 or less before admission to the hospital
  • Accident within the Regional Parisian area (Paris and 7 surrounding districts)

Exclusion Criteria:

  • Refusal to participate
  • Impossibility to contact the person
  • Current living place outside the Parisian area
  • Impossibility to answer the questionnaire, in the absence of a proxy to assist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Severe cranial trauma
This is a cohort of adult patients who have suffered a severe TBI between 1 July 2005 and 1 May 2007.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glasgow Outcome Scale-Extended
Time Frame: Eight years post-injury (one unique all-including evaluation)
This scale is assessed by a structured interview about the difficulties the patient in simple or elaborate acts of daily life
Eight years post-injury (one unique all-including evaluation)

Secondary Outcome Measures

Outcome Measure
Time Frame
Neuropsychological testing: memory (California Verbal Learning Test), executive functioning (6-Elements Test, Dysexecutive Questionnaire by patient and caregiver), speed index (Trail Making Test, WAIS-IV Processing Speed Index).
Time Frame: Eight years post-injury (one unique all-including evaluation)
Eight years post-injury (one unique all-including evaluation)
TBI-related complaints, by patient and caregiver
Time Frame: Eight years post-injury (one unique all-including evaluation)
Eight years post-injury (one unique all-including evaluation)
Capacity of motor vehicle driving, independence in daily living activities
Time Frame: Eight years post-injury (one unique all-including evaluation)
Eight years post-injury (one unique all-including evaluation)
Socio-professional integration
Time Frame: Eight years post-injury (one unique all-including evaluation)
Eight years post-injury (one unique all-including evaluation)
Hospital Anxiety and Depression
Time Frame: Eight years post-injury (one unique all-including evaluation)
Eight years post-injury (one unique all-including evaluation)
Patient's quality of life (0-10 numeric scale, by patient and caregiver)
Time Frame: Eight years post-injury (one unique all-including evaluation)
Eight years post-injury (one unique all-including evaluation)
Quality of life of caregiver
Time Frame: Eight years post-injury (one unique all-including evaluation)
Eight years post-injury (one unique all-including evaluation)
Caregiver burden (ZARIT questionnaire)
Time Frame: Eight years post-injury (one unique all-including evaluation)
Eight years post-injury (one unique all-including evaluation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claire CJ Jourdain, MD, Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, 92380 Garches, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2014

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

April 1, 2018

Study Registration Dates

First Submitted

January 29, 2014

First Submitted That Met QC Criteria

January 30, 2014

First Posted (Estimate)

January 31, 2014

Study Record Updates

Last Update Posted (Actual)

November 20, 2017

Last Update Submitted That Met QC Criteria

November 17, 2017

Last Verified

November 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Injury

Subscribe